Consolidated Balance Sheets (USD $)	Sep. 30, 2011	Sep. 30, 2010
ASSETS
Cash and cash equivalents	$ 4,260,594	$ 26,568,243
Receivables	457,337	0
Prepaid expenses	2,028,531	298,719
Inventory used for R&D and manufacturing	1,571,182	1,476,234
Deferred rent - current portion	703,274	751,338
Total current assets	9,020,918	29,094,534
RESEARCH AND OFFICE EQUIPMENT AND LEASEHOLD IMPROVEMENTS-- Less accumulated depreciation of $3,034,018 and $2,626,759	1,032,881	1,264,831
PATENT COSTS- less accumulated amortization of $1,267,323 and $1,205,690	414,158	356,079
RESTRICTED CASH	0	21,357
DEFERRED RENT - net of current portion	6,486,566	7,068,184
DEPOSITS	1,670,917	0
TOTAL ASSETS	18,625,440	37,804,985
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	738,951	1,497,383
Accrued expenses	290,220	223,696
Due to employees	22,789	45,808
Related party loan	1,104,057	1,104,057
Convertible notes	4,999,000	0
Derivative instruments - current portion	69,552	424,286
Total current liabilities	7,224,569	3,295,230
Derivative instruments - net of current portion	2,192,521	6,521,765
Deferred revenue	125,000	125,000
Deferred rent	4,526	8,225
Total liabilities	9,546,616	9,950,220
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; authorized, 200,000 shares; no shares issued and outstanding	0	0
Common stock, $.01 par value--authorized 450,000,000 shares; issued and outstanding, 214,723,023 and 204,868,853 shares at September 30, 2011 and 2010, respectively	2,147,230	2,048,689
Additional paid-in capital	194,443,905	187,606,044
Accumulated deficit	(187,512,311)	(161,799,968)
Total stockholders' equity	9,078,824	27,854,765
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 18,625,440	$ 37,804,985